International Journal of Endocrinology and Metabolism

Published by: Kowsar

World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study

Mojtaba Lotfaliany 1 , 2 , Samaneh Akbarpour 2 , Neda Zafari 2 , Mohammad Ali Mansournia 3 , Samaneh Asgari 2 , Fereidoun Azizi 4 , Farzad Hadaegh 2 and Davood Khalili 2 , 5 , *
Authors Information
1 School of Population and Global Health, University of Melbourne, Victoria, Australia
2 Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
4 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Department of Biostatistics and Epidemiology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Endocrinology and Metabolism: July 2018, 16 (3); e59946
  • Published Online: July 10, 2018
  • Article Type: Research Article
  • Received: September 2, 2017
  • Revised: February 24, 2018
  • Accepted: June 30, 2018
  • DOI: 10.5812/ijem.59946

To Cite: Lotfaliany M, Akbarpour S, Zafari N, Mansournia M A, Asgari S, et al. World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study, Int J Endocrinol Metab. 2018 ; 16(3):e59946. doi: 10.5812/ijem.59946.

Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Alwan A. Global status report on noncommunicable disaeses 2010: World Health Organization. 2011. 3 p.
  • 2. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-21. doi: 10.1016/j.diabres.2011.10.029. [PubMed: 22079683].
  • 3. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4. [PubMed: 23245608].
  • 4. IDF Diabetes Atlas. Brussels, Belgium: International Diabetes Federation; 2014. Available from:
  • 5. Fact sheet cardiovascular disease:. World Health Organization; 2013. Available from:
  • 6. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11). e442. doi: 10.1371/journal.pmed.0030442. [PubMed: 17132052]. [PubMed Central: PMC1664601].
  • 7. Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care. 2007;30(10):2548-52. doi: 10.2337/dc07-0150. [PubMed: 17670917].
  • 8. Diabetes Prevention Program Research G. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003;26(9):2518-23. doi: 10.2337/diacare.26.9.2518. [PubMed: 12941712]. [PubMed Central: PMC1360736].
  • 9. Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143-64. doi: 10.1177/1090198104263660. [PubMed: 15090118].
  • 10. Carver CS, Scheier MF. Self-regulation of action and affect. Handbook of self-regulation: Research, theory, and applications. 2004. p. 13-39.
  • 11. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142(5):323-32. doi: 10.7326/0003-4819-142-5-200503010-00007. [PubMed: 15738451]. [PubMed Central: PMC2701392].
  • 12. Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10). e1001885. doi: 10.1371/journal.pmed.1001885. [PubMed: 26440803]. [PubMed Central: PMC4595218].
  • 13. Singh R. The Adverse Effects of Wealth on Cardiovascular Health: A Scientific Statement of the International College of Cardiology. Cardiol Angiol. 2013;1(1):9-22. doi: 10.9734/ca/2013/3375.
  • 14. Sidney S, Rosamond WD, Howard VJ, Luepker RV, National Forum for Heart D, Stroke P. The "heart disease and stroke statistics--2013 update" and the need for a national cardiovascular surveillance system. Circulation. 2013;127(1):21-3. doi: 10.1161/CIRCULATIONAHA.112.155911. [PubMed: 23239838].
  • 15. Singh RB, Anjum B, Takahashi T, Martirosyan DM, Pella D, De Meester F. Poverty is not the absolute cause of deaths due to non-communicable diseases. World Heart J. 2012;4(2/3):221.
  • 16. Woolf SH, Aron L. US Health in International Perspective:: Shorter Lives, Poorer Health. National Academies Press; 2013.
  • 17. Sposato LA, Saposnik G. Gross domestic product and health expenditure associated with incidence, 30-day fatality, and age at stroke onset: a systematic review. Stroke. 2012;43(1):170-7. doi: 10.1161/STROKEAHA.111.632158. [PubMed: 22033985].
  • 18. Gwatkin DR, Wagstaff A, Yazbeck AS. Reaching the poor with health, nutrition, and population services: what works, what doesn't, and why. World Bank Publications; 2005. doi: 10.1596/978-0-8213-5961-7.
  • 19. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9. [PubMed: 15364185].
  • 20. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997;277(7):535-42. [PubMed: 9032159].
  • 21. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353(9164):1547-57. doi: 10.1016/S0140-6736(99)04021-0. [PubMed: 10334252].
  • 22. Osmani S, Sen A. The hidden penalties of gender inequality: fetal origins of ill-health. Econ Hum Biol. 2003;1(1):105-21. doi: 10.1016/S1570-677X(02)00006-0. [PubMed: 15463967].
  • 23. Dollar D, Gatti R. Gender inequality, income, and growth: are good times good for women?: Development Research Group. Washington, DC: The World Bank; 1999.
  • 24. Sen A. The many faces of gender inequality. New republic; 2001. p. 35-9.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments